{"id":23120,"date":"2021-12-17T18:33:39","date_gmt":"2021-12-17T23:33:39","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=23120"},"modified":"2021-12-27T11:25:27","modified_gmt":"2021-12-27T16:25:27","slug":"ipo-pipeline-update-new-filings-week-ending-12-17-21","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-new-filings-week-ending-12-17-21\/","title":{"rendered":"IPO Pipeline Update: New Filings week ending 12.17.21"},"content":{"rendered":"<p><!--more--><\/p>\n<p>NEW FILINGS<\/p>\n<p>Company: Amylyx Pharmaceuticals, Inc.<br \/>\nSymbol: AMLX (Nasdaq)<br \/>\nDescription: Their mission is to develop therapies that change the treatment paradigm for amyotrophic lateral sclerosis, or ALS, and a broad range of neurodegenerative diseases by keeping neurons alive.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Goldman Sachs, SVB Leerink, Evercore ISI<br \/>\nCo-Manager(s): HC Wainwright<br \/>\nLink to Prospectus: Filed: 12-17-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: CinCor Pharma, Inc.<br \/>\nSymbol: CINC (Nasdaq)<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on developing our lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Morgan Stanley, Jefferies, Evercore ISI<br \/>\nCo-Manager(s): Oppenheimer<br \/>\nLink to Prospectus: Filed: 12-17-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: TPG Inc.<br \/>\nSymbol: TPG (Nasdaq)<br \/>\nDescription: They are a leading global alternative asset manager with approximately $109 billion in assets under management as of September 30, 2021.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: J.P. Morgan, Goldman Sachs, Morgan Stanley, TPG Capital, BofA Securities, Citigroup, Deutsche Bank Securities, Evercore ISI, UBS Investment Bank, Wells Fargo Securities, BMO Capital Markets, Barclays<br \/>\nCo-Manager(s): Mizuho Securities, Keefe Bruyette &amp; Woods, MUFG, SMBC Nikko, AmeriVet Securities, Blaylock Van, C.L. King &amp; Associates, Drexel Hamilton, R. Seelaus &amp; Co., Ramirez &amp; Co., Siebert Williams Shank<br \/>\nLink to Prospectus: Filed: 12-16-21<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Justworks, Inc.<br \/>\nSymbol: JW (Nasdaq)<br \/>\nDescription: Justworks is a cloud-based software platform that gives small and medium-sized businesses (\u201cSMBs\u201d) access to benefits, payroll, human resources (\u201cHR\u201d), and compliance support\u2014all in one place.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Goldman Sachs, J.P. Morgan, BofA Securities<br \/>\nCo-Manager(s): Baird, Piper Sandler, Raymond James, Stifel, William Blair, Siebert Williams Shank<br \/>\nLink to Prospectus: Filed: 12-16-21<br \/>\nListed Cash Raise: $100m<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058,1536],"tags":[],"class_list":["post-23120","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/23120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=23120"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/23120\/revisions"}],"predecessor-version":[{"id":23121,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/23120\/revisions\/23121"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=23120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=23120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=23120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}